Detalhe da pesquisa
1.
Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
Liver Transpl
; 24(10): 1425-1436, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30021061
2.
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4.
J Hepatol
; 62(5): 1047-55, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596313
3.
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Gastroenterology
; 147(1): 132-142.e4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704719
4.
Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach.
Liver Transpl
; 19(1): 69-77, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23008144
5.
Current management and perspectives for HCV recurrence after liver transplantation.
Liver Int
; 33 Suppl 1: 56-62, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23286847
6.
Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
Med Mycol
; 51(2): 155-63, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22800082
7.
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.
J Hepatol
; 57(3): 564-71, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22613001
8.
Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.
Antimicrob Agents Chemother
; 56(11): 5728-34, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22908172
9.
Hepatitis C virus treatment pre- and post-liver transplantation.
Liver Int
; 32 Suppl 1: 120-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22212582
10.
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease.
Clin Gastroenterol Hepatol
; 9(3): 242-8, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21056689
11.
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Hepatology
; 47(2): 407-17, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18098295
12.
Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?
J Hepatol
; 52(5): 630-2, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20334948
13.
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
AIDS
; 29(1): 53-8, 2015 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25387314
14.
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.
Clin Res Hepatol Gastroenterol
; 39(4): 443-50, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636238
15.
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
PLoS One
; 10(9): e0138091, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394142
16.
Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.
J Hepatol
; 50(4): 652-4, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19231019
17.
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.
AIDS
; 27(16): 2655-7, 2013 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23939241